Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Business Overview and Strategic Initiatives
VTRS logo

Viatris Navigates $370 Million Manufacturing Hit and $2.94 Billion Impairment While Returning $1 Billion to Shareholders

VTRS10-KFiling Date: 2/26/2026
Viatris Inc.
Description

What this story covers

Viatris Inc. is transforming, divesting to focus on innovation. Despite a $2.94 billion impairment and Indian manufacturing issues, the company maintained strong cash flow and returned over $1 billion to shareholders.

Story snapshot

CompanyViatris Inc.
TickerVTRS
VariantStandard detailed
Duration13:40
Filing type10-K
PeriodAnnual 2025
IndustryHealthcare & Pharmaceuticals
Accession0001792044-26-000013
Sources1

Full Story Script

Content not available for this story.

Primary Sources

sec_filing10-KView on SEC.gov →

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in